Recipharm Strengthens its Group Management Team

Recipharm, one of Europe’s leading Contract Development and Manufacturing Organisations (CDMO), has strengthened its corporate Group Management Team by establishing a new position.

Dr. Carl-Johan Spak will take up the role of Vice President New Ventures with specific responsibility for Intellectual Property Management, in and out licensing activities, investments and Recipharm’s involvement in the biotechnology field. Dr. Spak has a long background in the pharmaceutical business from Pharmacia, Recip and Meda in leading positions.

Thomas Eldered, CEO of Recipharm commented, “We are very happy to be able to recruit Dr. Spak to Recipharm. In order to become one of Europe’s leading CDMO’s we need to be active and strengthen our position in new areas. The new role is a direct response to this need and we wish him all success in his new position”.